Phenotypes of Patients with Direct Oral Anticoagulant (DOAC) Underdosing in Atrial Fibrillation: Results from the ARENA Registry
C Brockmüller, AD Meid, J Senges, M Hochadel… - Clinical Drug …, 2024 - Springer
Methods The prospective ARENA registry is a multi-centre study on patients with atrial
fibrillation in Germany. Patients gave detailed information on medication, including over-the …
fibrillation in Germany. Patients gave detailed information on medication, including over-the …
Direct-Acting Oral Anticoagulants and Potential Inconsistencies with FDA-Approved Dosing for Non-Valvular Atrial Fibrillation: A Retrospective Real-World Analysis …
B DeLor, JJ Glover, TJ Hartman, LL Manzey… - Journal of general …, 2024 - Springer
Background Direct-acting oral anticoagulants (DOACs) are recommended to reduce risk of
stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) …
stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) …
Effectiveness and safety of Dabigatran 110 mg versus 150 mg for Stroke Prevention in Patients with Atrial Fibrillation at High Bleeding Risk
Purpose The effectiveness and tolerability of a reduced dose (110 mg) of dabigatran versus
the standard dose (150 mg) were evaluated in subgroups of patients with atrial fibrillation …
the standard dose (150 mg) were evaluated in subgroups of patients with atrial fibrillation …
Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation in the United States
A Sandhu, LA Kaltenbach, K Chiswell… - … Quality and Outcomes, 2023 - Am Heart Assoc
BACKGROUND: Among patients hospitalized for atrial fibrillation, the frequency of off-label
direct oral anticoagulant (DOAC) dosing, associated factors, hospital-level variation, and …
direct oral anticoagulant (DOAC) dosing, associated factors, hospital-level variation, and …
Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation
A Sandhu, LA Kaltenbach, K Chiswell, V Shimoga… - medRxiv, 2023 - medrxiv.org
Introduction Among patients hospitalized for atrial fibrillation (AF), the frequency of off-label
direct oral anticoagulant (DOAC) dosing, associated factors, hospital-level variation, and …
direct oral anticoagulant (DOAC) dosing, associated factors, hospital-level variation, and …
Effectiveness and Safety of Dabigatran 110 Mg Versus 150 Mg for High Bleeding Risk Patients with Atrial Fibrillation
Background: We evaluated the effectiveness and safety of reduced dose of dabigatran (110
mg) versus standard dose (150 mg) in high bleeding risk subgroups with AF. Methods: We …
mg) versus standard dose (150 mg) in high bleeding risk subgroups with AF. Methods: We …